ODI Pharma AB (XSAT:ODI) OCF Margin %: -4.85% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:ODI ODI Pharma AB XSAT:ODI
46 GF Score
Price kr2.26
GF Value kr9.52
Valuation Significantly Undervalued
View Full Analysis

What is ODI Pharma AB OCF Margin %?

ODI Pharma AB XSAT:ODI -11.02% 46 OCF Margin % is -4.85% as of Mar. 2026. GuruFocus rates XSAT:ODI with a GF Score™ of 46/100 and a GF Value™ of kr9.52 (Significantly Undervalued). Among 964 Drug Manufacturers companies, ODI Pharma AB ranks worse than 67.63% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. ODI Pharma AB's Cash Flow from Operations for the three months ended in Mar. 2026 was kr-0.62 Mil. ODI Pharma AB's Revenue for the three months ended in Mar. 2026 was kr12.71 Mil. Therefore, ODI Pharma AB's OCF Margin % for the quarter that ended in Mar. 2026 was -4.85%.

As of today, ODI Pharma AB's current OCF Yield % is 1.76%.

The historical rank and industry rank for ODI Pharma AB's OCF Margin % or its related term are showing as below:

XSAT:ODI' s OCF Margin % Range Over the Past 10 Years
Min: -3671.94   Med: -1230.7   Max: -17.16
Current: 2.51

During the past 7 years, the highest OCF Margin % of ODI Pharma AB was -17.16%. The lowest was -3671.94%. And the median was -1230.70%.

XSAT:ODI's OCF Margin % is ranked worse than
67.63% of 964 companies
in the Drug Manufacturers industry
Industry Median: 10.035 vs XSAT:ODI: 2.51

ODI Pharma AB OCF Margin % Related Terms

ODI Pharma AB OCF Margin % Historical Data

* Premium members only.

The historical data trend for ODI Pharma AB's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ODI Pharma AB OCF Margin % Chart

ODI Pharma AB Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Margin %
Get a 7-Day Free Trial 0.00 -2,355.91 -3,671.94 -17.16 -105.49

ODI Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -114.86 -34,733.33 24.46 18.15 -4.85

XSAT:ODI vs ZTS, UTHR, VTRS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ODI Pharma AB's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ODI Pharma AB OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ODI Pharma AB's OCF Margin % distribution charts can be found below:

* The bar in red indicates where ODI Pharma AB's OCF Margin % falls into.


XSAT:ODI
46GF Score
ODI Pharma AB XSAT:ODI
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ODI Pharma AB OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

ODI Pharma AB's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-3.306/3.134
=-105.49 %

ODI Pharma AB's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.617/12.712
=-4.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -4.85% mean?
ODI Pharma AB (XSAT:ODI) has a OCF Margin % of -4.85% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ODI Pharma AB and its competitors. According to the industry distribution chart, ODI Pharma AB ranks #652 out of 964 companies in the Drug Manufacturers industry, placing it in the top 67.6%.
Is ODI Pharma AB's OCF Margin % too high?
ODI Pharma AB's current OCF Margin % is -4.85%. Based on the distribution chart, ODI Pharma AB ranks #652 out of 964 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, ODI Pharma AB has a GF Score™ of 46/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ODI Pharma AB's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, ODI Pharma AB ranks #652 out of 964 companies for OCF Margin %. This places ODI Pharma AB in the lower half of its industry. The industry median OCF Margin % is 10.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ODI Pharma AB and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ODI Pharma AB's current OCF Margin % is -4.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ODI Pharma AB stock overvalued right now?
Based on GuruFocus' analysis, ODI Pharma AB (XSAT:ODI) is currently considered Significantly Undervalued. The stock's GF Value™ is kr9.52, compared to a current price of kr2.26 — trading 76.3% below its estimated fair value. The current OCF Margin % is -4.85%. ODI Pharma AB's overall GF Score™ is 46/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ODI Pharma AB (XSAT:ODI), the current OCF Margin % is -4.85% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ODI Pharma AB (XSAT:ODI) Overvalued in 2026?

Based on GuruFocus' analysis, ODI Pharma AB stock appears to be undervalued. The current stock price of kr2.26 is trading 76.3% below its estimated GF Value™ of kr9.52. GuruFocus considers ODI Pharma AB to be Significantly Undervalued.

Key valuation signals for XSAT:ODI:

  • OCF Margin %: -4.85%
  • GF Value™: kr9.52 vs. price of kr2.26 (76.3% below fair value)
  • GF Score™: 46/100

No single metric tells the full story. See the XSAT:ODI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ODI Pharma AB Business Description

Address Ostermalmstorg 1, Stockholm, SWE, 114 42
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.
46GF Score

Get the complete analysis for XSAT:ODI

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.26
Price
kr9.52
GF Value